.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Hearing loss significantly impacts individuals in low- and middle-income countries (LMICs). While surgical techniques advance, clinicians must carefully manage cochlear implant surgery complications to protect patient health. Social and structural factors often heighten these risks in resource-constrained environments. Consequently, understanding specific complication profiles is essential for surgical teams globally.
A recent systematic review of thirty studies reveals that complication rates differ by national income level. Specifically, lower-middle-income countries (L-MICs) experience a pooled average rate of 8.83%. In contrast, upper-middle-income countries (U-MICs) maintain a lower rate of 5.08%. Furthermore, the nature of these complications varies significantly between these classifications.
Facial nerve injuries appear more frequently in L-MICs than in other regions. Conversely, U-MICs report higher instances of vertigo, dizziness, and device failure. These differences likely reflect variations in surgical training, technological access, and perioperative infrastructure. Therefore, specialized expertise remains the primary facilitator of safe surgery.
Systemic and procedural issues often create hurdles for safe implantation. For instance, limited capacity and technological gaps can delay necessary interventions. However, multidisciplinary teams and meticulous perioperative planning can mitigate these barriers effectively. Moreover, widening access initiatives help ensure that safe surgery reaches more patients in need.
Overall complication rates in LMICs are generally comparable to those in high-income countries. However, limited follow-up data in some regions may lead to underreporting of late-stage issues.
Key barriers include limited surgical capacity, systemic healthcare issues, and lack of specialized technological support during the perioperative period.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
This systematic review examines cochlear implant surgery complications across 17 low- and middle-income countries. It identifies higher risks in lower-middle-income regions and highlights the necessity of specialized expertise and multidisciplinary teams to ensure patient safety and improve clinical outcomes.
2 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
